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Abstract
Background: Childhood depression is relatively common, under-researched and can im-
pact social and cognitive function and self-esteem.
Methods: Record linkage of routinely collected Scotland-wide administrative databases
covering prescriptions [prescribing information system (PIS)], hospitalizations (Scottish
Morbidity Records 01 and 04), maternity records (Scottish Morbidity Records 02), deaths
(National Records of Scotland), annual pupil census, school absences/exclusions, special
educational needs (Scottish Exchange of Educational Data; ScotXed), examinations
(Scottish Qualifications Authority) and (un)employment (ScotXed) provided data on
766 237 children attending Scottish schools between 2009 and 2013 inclusively. We com-
pared educational and health outcomes of children receiving antidepressant medication
with their peers, adjusting for confounders (socio-demographic, maternity and comor-
bidity) and explored effect modifiers and mediators.
Results: Compared with peers, children receiving antidepressants were more likely to be
absent [adjusted incidence rate ratio (IRR) 1.90, 95% confidence interval (CI) 1.85–1.95] or
excluded (adjusted IRR 1.48, 95% CI 1.29–1.69) from school, have special educational
needs [adjusted odds ratio (OR) 1.77, 95% CI 1.65–1.90], have the lowest level of aca-
demic attainment (adjusted OR 3.00, 95% CI 2.51–3.58) and be unemployed after leaving
school (adjusted OR 1.88, 95% CI 1.71–2.08). They had increased hospitalization [adjusted
hazard ratio (HR) 2.07, 95% CI 1.98–2.18] and mortality (adjusted HR 2.73, 95% CI 1.73–
4.29) over 5 years’ follow-up. Higher absenteeism partially explained poorer attainment
and unemployment. Treatment with antidepressants was less common among boys
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than girls (0.5% vs 1.0%) but the associations with special educational need and unem-
ployment were stronger in boys.
Conclusions: Children receiving antidepressants fare worse than their peers across a
wide range of education and health outcomes. Interventions to reduce absenteeism or
mitigate its effects should be investigated.
Key words: Depression, educational outcomes, health, population cohort, record linkage, prescribing
Background
Depression prevalence is estimated at 4.4% worldwide,1
4.7% in Western Europe2 and 6.4–12.2% in the UK.3
Estimates vary through differing ascertainment methods4–12
and because depression may be undiagnosed13 or untreated.
Worldwide, 2.6% of children and adolescents experience
depressive disorders and 1.3% major depression.14
Prevalence is increasing,15 higher amongst girls16–18 and
greater in older children, affecting 2.8% under 13 years of
age and 5.8% of adolescents.16,19 Management includes an-
tidepressant medication, cognitive–behavioural therapy and
psychotherapy. Childhood antidepressant use varies be-
tween 0.2% and 1.6% and is 1.1% in the UK.20–22 Whilst
antidepressants can treat several disorders, the most com-
mon prescribing reason is depression.23–26
Depression impacts cognition, social function and self-
esteem,5,6,27 and therefore potentially school performance.
Studies on school attendance are lacking and findings on
academic achievement4,5,7,27–30 and further/higher educa-
tion conflicting.7,8 Some suggest depressed children drop
out of school earlier,31,32 whereas others do not,8 and
results are inconsistent within studies.9 Data regarding all-
cause hospitalization and mortality are sparse, but reports
suggest depressed children suffer more violent, traffic-
related and unintentional injuries,33 increased non-suicidal
self-injury34 and suicide.35 Conflicting evidence may reflect
different ascertainment methodologies including: self,6–10
parental,7,11 teacher6 and peer12 report, physician diagno-
sis,5 hospitalization4 and attempted suicide.32 Previous
studies focused on a small number of outcomes, only two
included >10 000 participants11,28 and some were limited
by cross-sectional design.4,5,12,30
This study investigates outcomes for schoolchildren re-
ceiving antidepressants, regardless of indication, but with a
focus on the medications most likely to be prescribed for
depression. To our knowledge, it is the first countrywide
cohort study to compare a wide range of educational and
health outcomes between schoolchildren receiving antide-
pressants and peers. We questioned whether, compared
with peers, children receiving antidepressants: (i) have in-
creased school absenteeism; (ii) have increased school ex-
clusion; (iii) have greater special educational need (SEN);
(iv) have poorer academic attainment; (v) leave school ear-
lier; (vi) have higher unemployment; (vii) have increased
all-cause hospital admissions; (viii) have increased hospi-
talization for injury, poisoning or trauma; and (ix) have
greater mortality. We hypothesized that children receiving
antidepressants perform more poorly than peers across all
outcomes.
Methods
Databases
We linked Scotland-wide individual-level data from five
health and four education databases, held respectively by
the Information Services Division (ISD) of the National
Health Service and the Scottish Exchange of Educational
Data (ScotXed) described previously.36–41 The prescribing
information system (PIS) collects information from pre-
scriptions dispensed to Scottish residents by community
Key Messages
• Children receiving antidepressants have poorer education and health outcomes compared with their peers.
• Compared with peers, children receiving antidepressants have increased hospitalization and mortality, more school
absenteeism, greater school exclusion for challenging/disruptive behaviour, greater special educational need, poorer
academic attainment and increased unemployment.
• Absenteeism partially explained poorer attainment and unemployment. Interventions to reduce absenteeism or miti-
gate its effects should be investigated.
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pharmacies or primary care. The Scottish Morbidity
Record (SMR) 02 maternity database collects data pertain-
ing to mother and baby for all births in Scotland. SMR01
and SMR04 record acute and psychiatric hospital admis-
sions, including admission and discharge dates and
International Classification of Diseases (ICD-10) diagnos-
tic codes. National Records of Scotland collect death certif-
icates, including date and ICD-10 cause of death.
The pupil census, conducted annually by all Scottish lo-
cal-authority-run primary, secondary and special schools,
records demographic information and instances of SEN in-
cluding type. Absences and exclusions, collected prospec-
tively, are appended at the end of each year. The Scottish
Qualifications Authority collects exam results for school-
children sitting exams in the last 3 years of high school (S4–
S6). The school-leaver database records pupil whereabouts
3–6 months after leaving school: paid/voluntary employ-
ment, higher/further education, training or unemployment.
Inclusion criteria, definitions and outcomes
We included records for children appearing on at least one
pupil census between 2009 and 2013. The mean years of
school attendance during the study was 3.65 (range 1–5).
We excluded children aged <4 years or >19 years and re-
stricted the study to singletons. Using PIS data, we identi-
fied children prescribed at least one antidepressant during
the study period: any tricyclic antidepressant, selective se-
rotonin reuptake inhibitor (SSRI) or the serotonin norepi-
nephrine reuptake inhibitors mirtazapine or venlafaxine.
Children not prescribed an antidepressant listed above but
prescribed alternative antidepressants from the British
National Formulary (BNF) chapter 4.3 were excluded
from the study (Supplementary Figure 1, available as
Supplementary data at IJE online). Children not prescribed
any antidepressants comprised the peer group.
We studied six educational outcomes. (i) number of
days absent; (ii) number of exclusions (suspensions or
expulsions) for challenging/disruptive behaviour; and (iii)
records of SEN were recorded annually for every child and
analysed yearly. Absence and exclusion data were available
for 2009, 2010 and 2012. (iv) summarized academic
achievement; (v) percentage of children leaving school be-
fore 16 years of age; and (vi) subsequent unemployment,
were derived and analysed as single, end-of-school
outcomes.
SEN comprised intellectual disabilities, dyslexia, learning
difficulties physical/motor/sensory impairment, language/
speech disorder, autistic spectrum disorder, physical/mental
health problems and social/emotional/behavioural difficul-
ties. Academic achievement (low, basic, broad general or
high) was derived using total exam awards attained at each
level of the Scottish Credit Qualifications Framework
(SCQF) over the last 3 years of high school (S4–S6).37,42
Leaver destination was collapsed into education/employ-
ment/training or unemployment. Children were followed on
commencement of antidepressant treatment (exposed) or
their first school year (non-exposed) for three health out-
comes: (vii) all-cause hospitalization; (viii) hospitalization
for injury, poisoning or trauma (primary ICD-10 codes S00-
T98), including intentional self-harm (secondary ICD-10
codes X60–X84); and (ix) death. Hospitalizations and
deaths were available until September 2014, providing a
maximum of 5 years’ follow-up.
We adjusted for socio-demographic confounders. The
pupil census provided child’s age, gender and ethnicity.
Area socio-economic deprivation was derived from post-
code of residence using the Scottish Index of Multiple
Deprivation (SIMD) 2012 and children were allocated to
general-population quintiles. We also adjusted for mater-
nal and obstetric confounders, previously associated with
SEN.43–45 Linkage to SMR02 provided maternal age at de-
livery, parity, maternal smoking, gestation at delivery,
mode of delivery and 5-minute Apgar score, and we de-
rived sex- and gestation-specific birthweight centiles.
Finally, using PIS to identify children treated for attention
deficit hyperactivity disorder (ADHD),37,38 epilepsy,37,39
diabetes37,40 and asthma,37,41 we adjusted for chronic con-
ditions independently associated with poor educational
and health outcomes that can coexist alongside depres-
sion.37–41
Statistical analyses
Characteristics of children on antidepressants were com-
pared with peers using chi-square tests (categorical data)
and chi-square tests for trend (ordinal data). SEN, absen-
ces and exclusions were analysed as yearly outcomes us-
ing longitudinal generalized estimating equations (GEEs)
adjusting for correlated observations on the same pupil
across different years.46 The exposure, prescribed anti-
depressants over the same school year as the outcome,
predated each outcome. The user-written quasi-likeli-
hood under the independence model criterion (QIC) sta-
tistic47 compared different correlation structures with
the lowest trace QIC deemed most appropriate. SEN was
modelled using GEE analyses with a binomial distribu-
tion and logit link to produce odds ratios (ORs).
Numbers of days absent and number of exclusions were
modelled using GEE analyses with a negative binomial
distribution and log link to produce incidence rate ratios
(IRRs). The number of possible yearly attendances was
an offset variable adjusting for individual exposure time
in the latter two outcomes.
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Age at leaving school, subsequent unemployment, final
academic attainment, hospitalization and death were ana-
lysed as one-off outcomes using summarized data per pu-
pil. Longitudinal methods were not required and the
exposure, ever prescribed antidepressants during the study
period, predated each outcome. Age at leaving school (bi-
nomial), subsequent unemployment (binomial) and final
academic attainment (generalized ordinal) were analysed
using logistic regression to produce ORs. Hospitalization
and death were modelled using time-to-event analyses:
Cox proportional hazards to produce hazard ratios (HRs)
or Poisson piecewise regression to produce IRRs where the
proportionality assumption of the Cox model was not met.
In the time-to-event models, children prescribed antide-
pressants were followed from their treatment-commence-
ment date within the study period. The pupil census is
recorded each September, shortly after school term com-
mences. Children not prescribed antidepressants in the
study period were followed from their earliest pupil census
date, as previously described.37
All models were adjusted for socio-demographic and
maternity factors and co-morbid conditions. Model 1 was
unadjusted; Model 2 adjusted for age, sex, deprivation
quintile, ethnic group, maternal age, maternal smoking,
parity, mode of delivery, gestation at delivery, sex- and
gestation-specific birthweight centile and 5-minute Apgar
score; and Model 3 additionally adjusted for ADHD, epi-
lepsy, asthma and diabetes. We explored age, sex and dep-
rivation as effect modifiers by testing for statistical
interactions and undertaking subgroup analyses where
interactions were significant. We reanalysed the attainment
and unemployment models adjusting for absenteeism to
explore whether it was a mediator of either or both. We
also reanalysed unemployment adjusting for attainment to
uncover any mediating effect. We reran the original attain-
ment and unemployment models excluding children with
SEN. Finally we reran the main analyses using a new ex-
posed group, to compare children receiving fluoxetine, cit-
alopram or either with those receiving no antidepressants.
Children receiving antidepressants excluding fluoxetine or
citalopram were excluded from the analyses. All analyses
were undertaken using Stata MP version 14.1.
Supplementary Table 1, available as Supplementary data
at IJE online, summarizes the type and frequency of each
outcome variable, corresponding denominator popula-
tions, length of follow-up and analytical methods
employed.
Results
Between 2009 and 2013, 766 244 singleton children
attended Scottish schools and contributed 2 793 157 pupil
records. The mean school years contributed per pupil was
3.65 (range 1–5). Of 766 237 children eligible for inclu-
sion, 5342 (0.7%) received antidepressants during the
study period: 1752 (0.5%) boys and 3590 (1.0%) girls.
Antidepressants were dispensed in 20 328 of the 2 793 157
pupil school years analysed (0.7%). Children receiving
antidepressants were older on average than peers, less
likely to live in the most deprived quintile , smaller for ges-
tational age at birth and their mothers were more likely to
have smoked during pregnancy. They were more likely to
receive medication for diabetes, ADHD, epilepsy and
asthma (Table 1). The percentage of data missing within
each variable was <0.2% excluding parity (0.6%), Apgar
score (1.1%), ethnicity (1.8%) and smoking during preg-
nancy (9.9%) (Table 1). Missing values for the latter two
were analysed as ‘unknown’.
Antidepressant use varied by gender and age. Among
treated children, 67.2% were girls, 32.8% were boys,
18.0% commenced treatment at under 11 years of age,
44.9% aged 11–14 years and 37.1% over 14 years of age
(Supplementary Table 2, available as Supplementary data
at IJE online). Fluoxetine (41.1%), amitriptyline (31.5%),
sertraline (15.4%) and citalopram (11.9%) were the most
commonly prescribed medications and SSRIs (61.7%) the
most common drug class. Treatment over the period was
stable; 89.1% of children on antidepressants received one
drug type and 96.9% one drug class (Supplementary
Table 2, available as Supplementary data at IJE online).
Analyses of absences and exclusions included 1 597 379
pupil records for 702 203 children. Children on antidepres-
sants had more annual absences (median 15.5 vs 7.5 days
among peers) evident in Model 1 [IRR 2.23, 95% confi-
dence interval (CI) 2.17–2.29], Model 2 (IRR 1.95, 95%
CI 1.90–2.00) and Model 3 (IRR 1.90, 95% CI 1.85–
1.95). The association strengthened with age: IRR 2.01
(95% CI 1.94–2.07) >14 years of age compared with IRR
1.56 (95% CI 1.45–1.68) <11 years (interaction,
p< 0.001). The association weakened with increasing dep-
rivation (interaction, p< 0.001): IRR 2.37 (95% CI 2.21–
2.53) in the least-deprived quintile compared with IRR
1.56 (95% CI 1.48–1.66) in the most. However, this was
due to higher baseline absenteeism among children not on
antidepressants in deprived areas.
Children on antidepressants were more likely to be ex-
cluded in Model 1 (IRR 1.86, 95% CI 1.63–2.13), Model
2 (IRR 1.65, 95% CI 1.45–1.88) and Model 3 (IRR 1.48,
95% CI 1.29–1.69); 7.3% were excluded from school at
least once during the study period compared with 3.8% of
peers. The association was stronger in younger children;
IRR 2.11 (95% CI 1.36–3.27) <11 years of age compared
with IRR 1.38 (95% CI 1.16–1.65) >14 years (interaction,
p< 0.001).
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Table 1. Characteristics of schoolchildren by receipt of antidepressant medication
No antidepressants Antidepressants
N¼760 895 N¼5342
N % N % P-value
Socio-demographic factors (recorded annually on pupil census)
Sex
Male 388 537 51.1 1752 32.8 <0.001
Female 372 358 48.9 3590 67.2
Missing 0 0
Average age over all school years attended
Mean (SD) 10.92 (3.65) 14.00 (2.47) <0.001
Deprivation quintilea
1 (most deprived) 172 776 22.7 1016 19.1 <0.001
2 152 464 20.1 1102 20.7
3 146 776 19.3 1147 21.5
4 148 445 19.5 1077 20.2
5 (least deprived) 139 849 18.4 991 18.6
Missing 585 9
Ethnic group
White 722 929 96.2 5180 97.7 <0.001
Asian 17 715 2.4 62 1.2
Black 1963 0.3 2 0.0
Mixed 6684 0.9 44 0.8
Other 2064 0.3 12 0.2
Missing 9540 42
Medication prescribed for other conditions during study period
Diabetes 3271 0.4 59 1.1 <0.001
Asthma 45 312 6.0 587 11.0 <0.001
Epilepsy 4857 0.6 454 8.5 <0.001
ADHD 7222 0.9 191 3.6 <0.001
Maternity factors (recorded at time of birth)
Maternal age (years)
24 208 448 27.4 1430 26.8 0.015
25–29 222 830 29.3 1705 31.9
30–34 215 418 28.3 1515 28.4
35 114 187 15.0 692 13.0
Missing 12 0
Maternal smoking
No 487 887 72.4 3223 69.3 <0.001
Yes 186 356 27.6 1430 30.7
Missing 86 652 689
Parity
0 343 259 45.3 2404 45.1 0.648
1 262 234 34.6 1905 35.7
>1 151 541 20.0 1027 19.2
Missing 3861 6
Mode of delivery
SVD 512 522 67.4 3692 69.1 0.001
Assisted vaginal 91 041 12.0 616 11.5
Breech vaginal 2214 0.3 19 0.4
Elective CS 57 912 7.6 402 7.5
Emergency CS 97 041 12.8 613 11.5
Other 163 0.0 0 0.0
Missing 2 0
(Continued)
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A greater percentage of children on antidepressants had
a SEN compared with peers (27.4% vs 15.1%).
Associations with SEN were stronger in boys than girls and
increased with decreasing deprivation (interactions,
p< 0.001) based on analyses of 2 793 157 pupil records
pertaining to 766 237 children (Table 2).
On analysing exam grades for 139 199 children, 2340
(1.7%) received antidepressants. The percentage obtaining
the lowest level of academic attainment was greater among
children on antidepressants (7.6%) than peers (4.6%).
They were more likely to attain the lowest level of attain-
ment in Model 1 (OR 1.69, 95% CI 1.45–1.97), Model 2
(OR 3.44, 95% CI 2.89–4.09) and Model 3 (OR 3.00,
95% CI 2.51–3.58). The relative impact was lower in the
most deprived children (OR 3.09, 95% CI 2.22–4.29) than
in the least deprived (OR 5.72, 95% CI 3.37–9.70) (inter-
action, p< 0.001), due to the higher absolute risk among
unaffected children in deprived areas. Adjustment for ab-
senteeism attenuated the association (fully adjusted OR
1.65, 95% CI 1.35–2.02). The original association
remained after excluding children with SEN (fully adjusted
OR 2.99, 95% CI 2.38–3.77).
Of 217 919 school-leavers, 3394 (1.6%) received anti-
depressants. Quitting school before 16 years of age oc-
curred less among children on antidepressants (26.7%)
than peers (28.8%). However, the association disappeared
after adjusting for confounders (OR 0.98, 95% CI 0.90–
1.06). Unemployment was higher among children on anti-
depressants compared with peers (16.3% vs 10.3%). They
were more likely to be unemployed 6 months post school
in Model 1 (OR 1.69, 95% CI 1.54–1.85), Model 2 (OR
1.98, 95% CI 1.80–2.18) and Model 3 (OR 1.88, 95% CI
1.71–2.08). The association with unemployment was
stronger in boys (OR 2.30, 95% CI 1.96–2.69) than in
Table 1. Continued
No antidepressants Antidepressants
N¼760 895 N¼5342
N % N % P-value
Gestation (weeks)
<28 1143 0.1 11 0.2 0.013
28–32 6995 0.9 63 1.2
33–36 35 346 4.6 255 4.8
37 37 346 4.9 273 5.1
38 95 288 12.5 702 13.2
39 157 658 20.7 1080 20.2
40 228 780 30.1 1649 30.9
41 170 093 22.4 1099 20.6
42 26 926 3.5 198 3.7
>42 762 0.1 8 0.1
Missing 558 4
Sex-gestation-specific birthweight centile
1–3 31 253 4.1 232 4.3 0.003
4–10 68 129 9.0 517 9.7
11–20 90 638 11.9 710 13.3
21–80 447 064 58.8 3054 57.2
81–90 64 925 8.5 437 8.2
91–97 40 949 5.4 270 5.1
98–100 16 963 2.2 116 2.2
Missing 974 6
5-minute Apgar
1–3 3674 0.5 35 0.7 0.180
4–6 7252 1.0 50 0.9
7–10 742 161 98.5 5244 98.4
Missing 7808 13
ADHD, attention deficit hyperactivity disorder; N, number; SVD, spontaneous vaginal delivery; CS, Caesarean section. P-values created using chi-square tests
for categorical data, chi-square tests for trend for ordinal data and t-tests for continuous data (age).
aDeprivation quintile can change across different school years if a child’s family move house. Therefore, the most commonly occurring deprivation quintile was
chosen for each pupil across all of their school records in the study period. If two or more deprivation quintiles occurred equally, then the last known deprivation
quintile was used in the analyses.
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girls (OR 1.71, 95% CI 1.51–1.94) (interaction, p¼ 0.001)
(Figure 1). The relative association was also stronger in the
least (OR 2.57, 95% CI 1.98–3.33) than the most (OR
1.60, 95% CI 1.31–1.97) deprived quintiles (interaction,
p< 0.001), again reflecting underlying absolute risk.
Associations with unemployment remained after excluding
children with SEN (fully adjusted OR 1.97, 95% CI 1.76–
2.21). Adjusting the original model for absenteeism (fully
adjusted OR 1.36, 95% CI 1.23–1.51) and then adding at-
tainment (fully adjusted OR 1.30, 95% CI 1.13–1.49) also
attenuated the original association.
Over 4.33 years’ follow-up (range 1–5 years), 157 291
(20.5%) of 766 237 children were hospitalized. More
children receiving antidepressants were hospitalized
(34.2%) than peers (20.4%). A Cox regression model
reflected this (fully adjusted HR 2.07, 95% CI 1.98–2.18)
although proportional hazards were not met (p< 0.001).
Therefore, Poisson piecewise regression models, stratified
by sex, were run by period of follow-up (Figure 2) and
age of child at hospital admission (Figure 3). Children on
antidepressants had an elevated risk of hospitalization
throughout, particularly in the first year of follow-up
(Figure 2) and between 11 and 16 years of age (Figure 3).
The association was stronger in girls than in boys
(Figures 2 and 3). Injury, poisoning and trauma
accounted for 27.8% of hospitalizations among children
on antidepressants compared with 21.3% among peers.
Further, 9.5% of children on antidepressants had at least
Table 2. Association between receipt of antidepressants and record of special educational need: overall and by sex, aged and
area deprivation
Model 1 Model 2 Model 3
N¼2 793 157 (766 237) N¼2 741 516 (753 133) N¼2 741 516 (753 133)
OR 95% CI OR 95% CI OR 95% CI
Overall 1.99 1.87–2.12 2.24 2.10–2.39 1.77 1.65–1.90
Boysa 2.71 2.47–2.97 2.66 2.42–2.94 2.06 1.85–2.30
Girlsa 2.02 1.86–2.20 1.93 1.77–2.11 1.54 1.40–1.70
<11 yearsb 2.74 2.36–3.19 2.73 2.32–3.20 2.01 1.68–2.41
11–14 yearsb 1.52 1.39–1.67 1.78 1.62–1.96 1.42 1.28–1.58
>14 yearsb 2.00 1.86–2.15 2.46 2.29–2.65 1.99 1.84–2.16
1 (more deprived)c 1.60 1.40–1.83 1.73 1.51–1.98 1.36 1.17–1.58
2c 1.86 1.63–2.13 2.05 1.79–2.35 1.62 1.39–1.88
3c 1.94 1.70–2.21 2.19 1.91–2.50 1.73 1.49–2.01
4c 2.40 2.09–2.75 2.72 2.37–3.13 2.15 1.84–2.51
5 (least deprived)c 2.70 2.32–3.13 2.93 2.51–3.42 2.32 1.96–2.74
Model 1—unadjusted.
Model 2—adjusted for age at outcome, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity, mode of delivery, gestation at delivery,
sex- and gestation-specific birthweight centile and 5-minute Apgar score.
Model 3—also adjusted for co-morbid conditions (diabetes, asthma, epilepsy and attention deficit hyperactivity disorder).
N—number of records (number of children).
aSubgroups therefore not adjusted for sex.
bSubgroups therefore not adjusted for age.
cSubgroups therefore not adjusted for deprivation quintile.
dAge—age at receiving special educational need.
OR, odds ratio; CI, confidence interval.
All p< 0.001.
Figure 1. Forest plot of the associations between antidepressant treat-
ment and unemployment among 217 919 schoolchildren: overall and
by sex and area deprivation. Adjusted for age, sex, deprivation quintile
and ethnic group, maternal age, maternal smoking, parity, mode of de-
livery, gestation at delivery, sex- and gestation-specific birthweight cen-
tile, 5-minute Apgar score and co-morbid chronic conditions (attention
deficit hyperactivity disorder, epilepsy, asthma, diabetes). SIMD,
Scottish Index of Multiple Deprivation. Solid circles/triangles/squares
denote odds ratios; bars denote 95% confidence intervals.
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one admission for injury, poisoning or trauma compared
with 4.3% of peers. Amongst children on antidepressants
admitted for injury, poisoning or trauma, 66.6% were for
intentional self-harm. The corresponding percentage
among peers was 10.0%. The average age for all first in-
jury, poisoning or trauma admissions was 12.82 years
(SD¼ 4.40) but higher for intentional self-harm
[16.53 years (SD¼ 2.07)] than for unintentional injury
[12.36 years (SD¼4.40)]. Over follow-up, 491 children
(22 on antidepressants and 469 peers) among 766 237
children attending school between 2009 and 2013 died.
Risk of death was higher among children on antidepres-
sants in Model 1 (HR 5.76, 95% CI 3.74–8.88), Model 2
(HR 6.25, 95% CI 4.05–9.65) and Model 3 (HR 2.73,
95% CI 1.73–4.29). When the main models were rerun
using the more stringent definition of antidepressant med-
ication, the associations persisted and were generally
greater in magnitude (Table 3).
Discussion
Children on antidepressants fared worse than peers across
various outcomes: more school absences and exclusions;
greater SEN and unemployment; poorer examination
results; and excess hospitalization and death. Poorer at-
tainment and higher unemployment were partially
explained by increased absenteeism.
Gender differences in depression prevalence vary with
age. Within our study period, commencement of antide-
pressants in girls was comparable to boys below 11 years
of age, but two-fold higher in older age groups. Previous
studies report lower depression prevalence in girls before
13–14 years of age, but double that of boys above this
age.31,48 Reasons include under-diagnosis and under-treat-
ment among boys,31 more biological and social challenges
for girls entering adolescence49 and poorer coping mecha-
nisms among girls.48
In our study, antidepressants were associated with
worse educational outcomes in boys. Depressive symp-
toms, such as self-criticism and helplessness, are inconsis-
tent with society’s expectations of male behaviour;
therefore, parents, teachers and peers may support boys
less.50 In contrast, girls on antidepressants were more
likely to be hospitalized. Further research should determine
whether this reflects worse health or a greater willingness
to seek medical help. Previous studies reported gender dif-
ferences in academic performance, some reporting stronger
associations in boys11,51 and others in girls.6–9,52,53
Depressed children often present with irritability, rest-
lessness, aggression and hyperactivity, especially in early
childhood.54 Dominant symptoms in adolescence are sui-
cidal thoughts, hopelessness, social isolation, drug or alco-
hol use, overeating, oversleeping and rage.13 This could
explain the stronger association with school exclusion in
younger children and the stronger association with absence
in adolescence.
Receipt of antidepressants is a reasonable proxy of de-
pression, more objective and less prone to bias, than self,
parental or teacher reports, but cannot differentiate disease
and medication effects, may only identify children with se-
vere symptoms and may be incomplete due to misdiagnosis
Figure 2. Forest plot of the association between antidepressant treat-
ment and all-cause hospitalization among 766 237 schoolchildren by
time from commencement of treatment and by sex. Adjusted for age,
deprivation quintile and ethnic group, maternal age, maternal smoking,
parity, mode of delivery, gestation at delivery, sex- and gestation-spe-
cific birthweight centile, 5-minute Apgar score and co-morbid chronic
conditions (attention deficit hyperactivity disorder, epilepsy, asthma, di-
abetes). SIMD, Scottish Index of Multiple Deprivation. Boys ¼ solid
square; girls ¼ hollow diamond; bars denote 95% confidence intervals.
Figure 3. Forest plot of the association between antidepressant treat-
ment and all-cause hospitalization among 766 237 schoolchildren by
age at first admission in follow-up and by sex. Adjusted for age, depri-
vation quintile and ethnic group, maternal age, maternal smoking, par-
ity, mode of delivery, gestation at delivery, sex- and gestation-specific
birthweight centile, 5-minute Apgar score and co-morbid chronic condi-
tions (attention deficit hyperactivity disorder, epilepsy, asthma, diabe-
tes). SIMD, Scottish Index of Multiple Deprivation. Boys ¼ solid square;
girls ¼ hollow diamond; bars denote 95% confidence interval.
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or under-treatment, especially in boys.13 Additionally,
we only had prescribing data from 2009 onwards.
Nevertheless, ascertainment of cases using school, not
health, records ensured non-restriction to severe hospital-
ized depression. Antidepressants are not required for all
cases of childhood depression; some are used for condi-
tions such as anxiety, obsessive compulsive disorder or en-
uresis. Without primary-care records, we could not
confirm the clinical indications for medication. However,
previous studies report that depression is the main reason
for prescribing SSRI antidepressants.23–26 We partially
addressed this limitation by repeating our analyses includ-
ing only children receiving fluoxetine (the recommended
treatment and only drug licensed in the UK for treating de-
pression in children under 16 years of age) and citalopram
(the most common second-line treatment). Whilst these
can be prescribed for other indications, a previous study
demonstrated that 62.4% and 62.2% of children pre-
scribed fluoxetine and citalopram were depressed.24
Associations remained after running these sensitivity analy-
ses and were stronger than previously observed, suggesting
our initial findings were unlikely to have been due to
misclassification.
Ours was a large, non-selective study covering the
whole of Scotland. The relationship between depression
and academic performance can be bidirectional,6 challeng-
ing the robustness of previous cross-sectional studies. A co-
hort approach ensured antidepressant use predated
education and health outcomes. We adjusted for several
confounders; however, residual confounding is possible in
any observational study. Consistent with previous studies,
schoolchildren taking antidepressants had more co-morbid
conditions. By including treatment of ADHD, epilepsy, di-
abetes and asthma as covariates, we demonstrated that ad-
verse outcomes were independently associated with
antidepressant treatment, not merely coexisting conditions.
The large study population provided sufficient power to
test for interactions and conduct subgroup analyses, and
we analysed a wide range of outcomes in the same cohort.
Missing data across all covariates did not exceed 1.9%
and, for most analyses, were considerably lower. Given the
sample size, we do not believe this affected the results and
therefore did not impute data or run sensitivity analyses.
The study included only local-authority-maintained
schools. However, in Scotland, only 5% of children attend
private schools. In the 2011 Scottish Census, 11% of
Scottish residents aged 5–19 years were born outside of
Scotland, consistent with the 12% of schoolchildren we
could not link to maternity records. Prevalence of antide-
pressant treatment was 0.7% among linked and unlinked
Table 3. Comparison of results based on narrow and wide definitions of antidepressant medication
Fluoxetine Citalopram Fluoxetine or Citalopram Any antidepressant
N¼766 237 (2200) N¼766 237 (638) N¼766 237 (2692) N¼766 237 (5342)
Effect size 95% CI Effect size 95% CI Effect size 95% CI Effect size 95% CI
Absenceg 2.18 2.09–2.27 2.03 1.88–2.19 2.14 2.06–2.21 1.90 1.85–1.95
Exclusion for disruptive behaviourg 1.51 1.26–1.81 1.47a 1.05–2.06 1.55 1.32–1.82 1.48 1.29–1.69
SENh 2.13 1.92–2.36 1.57 1.28–1.94 2.02 1.84–2.23 1.77 1.65–1.90
Attainmenti General/basic/low 2.24 1.91–2.61 2.34 1.87–2.92 2.26 1.97–2.60 1.86 1.68–2.05
Basic/low 2.75 2.34–3.24 2.34 1.87–2.92 2.74 2.37–3.17 1.99 1.78–2.23
Low 4.44 3.52–5.60 2.34 1.87–2.92 3.83 3.07–4.77 3.00 2.51–3.58
High (reference) 1.00 1.00 1.00 1.00
Left school before 16 years of agej 1.25 1.11–1.41 0.72b 0.58–0.91 1.11c 1.00–1.24 0.98d 0.90–1.06
Unemploymentj 2.60 2.28–2.97 2.21 1.73–2.83 2.48 2.20–2.80 1.88 1.71–2.08
Admissionk 2.50 2.33–2.69 2.16 1.89–2.46 2.41 2.26–2.57 2.07 1.98–2.18
Mortalityk 3.21e 1.56–6.58 1.43f 0.20–10.22 3.00e 1.52–5.91 2.73 1.73–4.29
*Adjusted for age, sex, deprivation quintile, ethnic group, maternal age, maternal smoking, parity, mode of delivery, gestation at delivery, sex- and gestation-
specific birthweight centile, 5-minute Apgar score and co-morbid conditions (diabetes, asthma, epilepsy and attention deficit hyperactivity disorder).
N—total number of children (total number of children on medication).
OR, odds ratio; CI, confidence interval.
All p< 0.001 with the exception of: ap< 0.05; bp¼ 0.005; cp¼ 0.051; dp¼ 0.559; ep¼ 0.001; fp¼ 0.722.
g1 597 379 records (702 203 pupils) analysed using Generalised Estimating Equations with a negative binomial distribution and log link function to produce in-
cidence rate ratios (IRRs).
h2 793 157 records (766 237 pupils) analysed using Generalised Estimating Equations with a binomial distribution and logit link function to produce odds ra-
tios (ORs).
i139 199 pupils analysed using generalized ordinal logistic regression to produce ORs.
j217 919 pupils analysed using binomial logistic regression to produce ORs.
k766 237 pupils analysed using Cox regression to produce hazard ratios (HRs).
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pupils, suggesting bias was unlikely. The study used ad-
ministrative databases established for other purposes that
undergo regular quality assurance. Education and health
records were linked using probabilistic matching, validated
as 99% accurate for singletons.36
Conclusion
Children with mental health conditions severe enough to
require antidepressants fare poorly across a range of educa-
tional and health outcomes. In boys, antidepressant use
was less common but associated with worse outcomes.
Affected children should be identified early and supported
to reduce the risk of school absence or exclusion and mini-
mize longer-term impacts on employment and health.
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Supplementary data are available at IJE online.
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